Shares of FibroGen jumped 5.79% to $20.09 at 15:14 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is falling 1% to $13,774.94, following last session’s downward trend, This seems, as yet, a somewhat negative trend exchanging session today.
FibroGen’s last close was $19.00, 184.77% below its 52-week high of $57.21.
The company’s growth estimates for the ongoing quarter and the next is 2.2% and 62.1%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $20.09 at 15:14 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $18.77.
FibroGen’s Moving Average
FibroGen’s worth is way under its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.
More news about FibroGen.